The basis for limited specificity and MHC
restriction in a T cell receptor interface by Piepenbrink, Kurt H. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Biochemistry -- Faculty Publications Biochemistry, Department of 
2013 
The basis for limited specificity and MHC restriction in a T cell 
receptor interface 
Kurt H. Piepenbrink 
Sydney J. Blevins 
Daniel R. Scott 
Brian M. Baker 
Follow this and additional works at: https://digitalcommons.unl.edu/biochemfacpub 
 Part of the Biochemistry Commons, Biotechnology Commons, and the Other Biochemistry, Biophysics, 
and Structural Biology Commons 
This Article is brought to you for free and open access by the Biochemistry, Department of at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Biochemistry -- Faculty 
Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
ARTICLE
Received 22 Oct 2012 | Accepted 30 Apr 2013 | Published 5 Jun 2013
The basis for limited specificity and MHC
restriction in a T cell receptor interface
Kurt H. Piepenbrink1,w, Sydney J. Blevins1, Daniel R. Scott1 & Brian M. Baker1,2
ab Tcell receptors (TCRs) recognize peptides presented by major histocompatibility complex
(MHC) proteins using multiple complementarity-determining region (CDR) loops.
TCRs display an array of poorly understood recognition properties, including specificity,
crossreactivity and MHC restriction. Here we report a comprehensive thermodynamic
deconstruction of the interaction between the A6 TCR and the Tax peptide presented by the
class I MHC HLA-A*0201, uncovering the physical basis for the receptor’s recognition
properties. Broadly, our findings are in conflict with widely held generalities regarding TCR
recognition, such as the relative contributions of central and peripheral peptide residues and
the roles of the hypervariable and germline CDR loops in engaging peptide and MHC. Instead,
we find that the recognition properties of the receptor emerge from the need to engage the
composite peptide/MHC surface, with the receptor utilizing its CDR loops in a cooperative
fashion such that specificity, crossreactivity and MHC restriction are inextricably linked.
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R
ecognition of peptide antigens by the ab T cell receptor
(TCR) underlies cellular immunity. TCRs recognize pep-
tides bound and presented by major histocompatibility
complex (MHC) proteins, using multiple complementarity-
determining region (CDR) loops to contact the composite
peptide-MHC surface (pMHC). A notable aspect of the TCR–
pMHC interaction is that the distribution of binding energy
within the interface has significant functional implications. The
immune response is directed towards the peptide, yet TCRs
invariably contact both peptide and MHC. It is commonly
expected that contacts between the TCR and peptide should be
stronger than those between TCR and MHC to ensure antigen
specificity. Within this framework, the various CDR loops have
often been ascribed ‘roles’ in TCR recognition, with weak
recognition of the MHC attributed to the germline-encoded
CDR1 and CDR2 loops and recognition of the peptide attributed
to the hypervariable CDR3 loops. While this view logically pairs
the diverse and genetically conserved regions of the TCR–pMHC
interface (peptide with CDR3; MHC with CDR1/CDR2), such
simplifying distinctions are rarely evident in TCR–pMHC
crystallographic structures1.
Several studies have attempted to address the energetic
contributions of different interfacial regions to TCR–pMHC
binding through mutagenesis, and alanine scans of both receptor
and ligand have been performed2–5. Varying conclusions from
these studies together with the growing number of TCR–pMHC
structures have indicated that the energetic contributions of
regions will likely vary among TCR–pMHC interfaces6. Thus,
alanine scans have been followed with more targeted
substitutions, aiming to identify trends that might yield insight
into phenomena such as MHC restriction, peptide specificity or
TCR crossreactivity.
However, while single mutagenesis is useful for examining
regions that influence binding and specificity, single mutations
cannot probe the strengths of pairwise interactions and provide
poor estimates of the contributions of sidechains to binding affinity.
These caveats have been reviewed in detail7, and in one case
resulted in incorrect conclusions regarding TCR specificity8. More
direct measurements of energetic contributions to binding are
obtainable from double-mutant cycles, which can account for both
structural and energetic responses to mutations and permit the
direct probing of the strengths of interactions between sidechains9.
Here, we utilize double-mutant cycles to dissect the interface
between the ab TCR A6 and its best studied ligand, the Tax
peptide presented by the class I MHC HLA-A*0201 (HLA-A2).
The significant amount of structural, biophysical and functional
data available for the A6 TCR provided context in which to
interpret the measurements. For comparison, select measure-
ments are repeated with two additional TCR–pMHC pairs. Our
observations, several of which conflict with widely held general-
ities regarding TCR recognition, shed new light on the origin of
TCR-limited specificity and MHC restriction, two defining
features of TCR recognition for which a variety and sometimes
competing explanations have been offered. Conclusions applic-
able to TCR recognition in general relate to the role of
hypervariable loop flexibility in promoting limited rather than
tight specificity, and that TCR specificity and MHC restriction
can be inextricably linked, the latter reflecting the fact that the
TCR must engage a composite peptide/MHC ligand with tightly
coupled structural properties.
Results
Double-mutant cycles in the A6 TCR—Tax/HLA-A2 interface.
We began by identifying all interacting sidechains in the interface
between the A6 TCR and Tax/HLA-A2 (ref. 10). There are 21 such
pairs, involving 16 amino acids of the TCR, 10 of HLA-A2 and 3 of
the peptide. The interaction free energy (DGint) between each pair
was measured via double-mutant cycles. Including controls, 38
cycles in the A6-Tax/HLA-A2 interface were performed. Eight
additional cycles were performed in the interfaces between the B7
TCR and Tax/HLA-A2 and the DMF5 TCR and MART-126(27L)-35/
HLA-A2. The data were collected and analysed using a strategy in
which all four measurements of a cycle were performed in a single
surface plasmon resonance experiment and the data fit globally.
This approach substantially increased sensitivity and improved
accuracy and reproducibility compared with the traditional
approach in which cycles are constructed from independently
measured values.
A representative double-mutant cycle is shown in Fig. 1a, and the
results of all cycles are listed in Supplementary Tables S1 and S2.
Errors in the DGint measurements ranged from ±0.1 to
±0.5 kcalmol 1, with an average error of ±0.1 kcalmol 1.
Reproducibility was excellent: each cycle included two replicates,
and seven cycles were performed at least two additional times. In all
but one case the DGint values for repeated cycles were identical
within error, and in the single outlying case the values were weak.
In all but one easily rationalized case, cycles repeated with different
amino acids (for example, separate cycles with alanine and
phenylalanine substituted for pTyr5) yielded identical conclusions.
Control cycles performed between residues whose sidechain atoms
were far apart and not poised to interact yielded DGint values of
zero within error. The average DG for the interaction between
wild-type A6 and Tax/HLA-A2 was  7.6±0.1 kcalmol 1, in
excellent agreement with values determined previously11,12.
The DDG values resulting from single mutations were poorly
correlated with the DGint values involving the same sites (Fig. 1b).
Generally, the most destabilizing single mutations were
involved in the most favourable interactions, but quantitatively
the DDG values from the single mutations were poor predictors
of the strengths of these interactions. We found several cases
where single mutations had significant effects on binding, yet
the mutated sites participated in interactions that were either
negligible or weakly unfavourable, or vice versa. Two examples
are highlighted in Fig. 1b: the hydrogen bond between Thr98a of
A6 and Arg65 of HLA-A2 is significantly stronger than predicted
by the DDG of the T98aA mutation, and the van der Waals
interaction between Gln30a of A6 and Tyr159 of HLA-A2 is
almost negligible, despite the large DDG for the Y159A
mutation.
Interactions at the periphery dominate peptide contributions.
In the A6-Tax/HLA-A2 structure, eight sidechains of the TCR
interact with three of the peptide. The majority of the interactions
are made with pTyr5, which lies at the centre of the interface and
is accommodated in a pocket formed by the TCR a and b chains
(Fig. 2a). Two hydrogen bonds are formed to the tyrosine
hydroxyl, one between Ser31 of CDR1a and one with Arg95 of
CDR3b. Only the hydrogen bond with Ser31a was significant
(DGint of  0.9 kcalmol 1). The strength of the hydrogen bond
with Arg95b was negligible at  0.2 kcalmol 1, likely owing to
the entropic cost of ordering the flexible CDR3b loop13. The
remaining interactions with pTyr5 ranged from weakly
favourable to unfavourable. Summing the various DGint values
leads to a negligible contribution of  0.1 kcalmol 1 for the
interactions with the tyrosine sidechain. The data thus indicate
that contacts to tyrosine 5 contribute a negligible amount to the
affinity of A6 towards Tax/HLA-A2, despite the position of the
sidechain in the centre of the interface. Note that summation of
the DGint values assumes additivity between the double-mutant
cycles, an assumption subjected to caveats as described below.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2948
2 NATURE COMMUNICATIONS | 4:1948 | DOI: 10.1038/ncomms2948 | www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
However, the results explain the ability of T cells expressing A6 to
recognize targets presenting Tax variants with a wide range of
amino acids substituted for pTyr5, including alanine and bulky
non-natural amino acids14,15.
The sidechain of pLeu1 forms a single van der Waals
interaction with the sidechain of Gln30 of CDR1a. The Q30A
variant of the A6 a chain expressed poorly, prohibiting a cycle
with alanine at this position. However, substitutions with leucine
and valine could be made, both yielding an almost negligible
DGint of þ 0.2 kcalmol 1. Consistent with this result, A6 T cells
are widely tolerant of substitutions to pLeu1 (ref. 14).
As opposed to pTyr5, pTyr8 is at the periphery of the interface
and only interacts with two sidechains of A6. A hydrogen bond is
formed between the pTyr8 hydroxyl and the sidechain of Glu30
of CDR1b, and van der Waals contacts are formed between the
tyrosine ring and the sidechain of Leu98 of CDR3b. Both
interactions were found to be unusually strong (Fig. 2b): the DGint
for the pTyr8–Glu30b hydrogen bond was measured as
 1.7 kcalmol 1, and the DGint for the interactions with Leu98b
was measured as  1.6 kcalmol 1. The hydrogen bond mea-
surement was repeated twice, first in the background of an
affinity-enhancing modification to the pTyr5 sidechain16, and
second with a phenylalanine substitution at position 8. Both
measurements yielded results identical within error to the first.
The strength of the hydrogen bond likely arises because both
pTyr8 and Glu30b remain solvent-exposed after forming the
TCR–pMHC complex, minimizing the desolvation penalty that
occurs upon hydrogen bond formation17.
Overall, the data indicate that the sidechain of pTyr8
dominates the peptide side contribution to TCR-binding affinity.
This dominance is reflected in functional measurements with A6
T cells, which tolerate substitutions to the sidechain of tyrosine 8
poorly14. Further, unlike interactions to the centre of the peptide,
the interactions between the TCR and pTyr8 are conserved
across all ten crystal structures of A6 bound to different peptide/
HLA-A2 complexes10,12,13,15,16,18,19.
Interactions with CDR3a dominate a1 helix contributions.
Five sidechains of the A6 CDR1a and CDR3a loops interact with
a range of sidechains across the HLA–A2 a1 helix. The DGint
values were dominated by extremely favourable interactions
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Figure 2 | Cross-eyed stereo views of the interactions between the position 5 and position 8 tyrosines of the Tax peptide and sidechains of
the A6 TCR. (a) Engagement of pTyr5 at the centre of the interface by sidechains of CDR1a, CDR3a and CDR3b contributes little to TCR affinity.
Interactions between sidechains are highlighted by red lines, and the free energies of each interaction are indicated in units of kcalmol 1. (b) In contrast
with pTyr5, engagement of pTyr8 by sidechains of CDR1b and CDR3b contributes significantly to TCR affinity.
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Figure 1 | Double-mutant cycles in the A6-Tax/HLA-A2 interface. (a) Data for all four interactions defining a double-mutant cycle (in this example, the A6
T98a—Tax/HLA-A2 pY5 interaction) were collected in one experiment, in which duplicate concentration series of wild-type or mutant pMHC were
injected over adjacent flow cells coupled with wild-type or mutant TCR. All eight data sets were fit globally to a model in which the surface activities for the
four data sets over the wild-type TCR surface (indicated with red) and the four data sets over the mutant TCR surface (indicated with blue) were shared
parameters. Construction of the double-mutant cycle and the resulting interaction free energy for the T98a—pY5 interaction are shown to the right
of the plot. (b) For cycles in the A6-Tax/HLA-A2 interface, plotting the free energy of interaction of each residue (DGint) versus the effect of its mutation on
the binding free energy (DDG) showed that while the most destabilizing mutations were generally involved in the strongest interactions, the results
were poorly correlated. Two data points that illustrate the poor correlation are highlighted: the hydrogen bond between Thr98a of A6 and Arg65 of HLA-A2
is stronger than predicted by the DDG of the T98aA mutation, and the van der Waals interaction between Gln30a of A6 and Tyr159 of HLA-A2 is
almost negligible, despite the large DDG for the Y159A mutation. Error bars reflect standard parameter error from the global fits of eight data sets.
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between the sidechains of Thr98 and Asp99 of CDR3a and
Arg65 of the HLA-A2 a1 helix (Fig. 3a). The strength of the
hydrogen bond between Thr98a and Arg65 was measured as
 2.8 kcalmol 1. The salt bridge between Asp99a and Arg65
was even stronger, with two independent DGint measurements of
 3.4 and  3.0 kcalmol 1. These measurements could only be
made with the aid of affinity-enhancing substitutions in CDR3b
(ref. 20). However, a cycle could be performed without using an
altered CDR3b by mutating position 99 to an asparagine rather
than alanine. In that case, the DGint value was still an
exceptionally strong  2.5 kcalmol 1. Engagement of Arg65
thus contributes a remarkable degree of favourable binding free
energy: assuming additivity between the cycles, the total DGint
amounts to  5 to  6 kcalmol 1. The interactions between
Arg65 and residues of the hypervariable CDR3a loop account for
the largest energetic contributions measured in the A6-Tax/HLA-
A2 interface. The substantial contributions may reflect an optimal
electrostatic environment together with the reduced desolvation
penalty required for burial of an arginine21.
The remaining interactions between the TCR and the a1 helix
of HLA-A2 ranged from moderately favourable to weakly
unfavourable. The two interactions between the germline CDR1a
loop and the a1 helix were unfavourable, with DGint values of
þ 0.5 kcalmol 1 (Asp26a—Glu58) and þ 0.6 kcalmol 1
(Gln30a—Lys66).
Interactions with the a2 helix are at best moderate. Six side-
chains of the A6 TCR, including those from CDR1a, CDR2a,
HV4a and CDR3b, interact with eight sidechains across the
HLA–A2 a2 helix (Fig. 3b). Unlike the interactions with the
peptide or the a1 helix, the interactions between the TCR and the
a2 helix were not dominated by highly favourable interactions,
but rather had DGint values distributed between moderately
favourable and moderately unfavourable. The interactions
between sidechains of CDR1a and the a2 helix were all
unfavourable, with DGint values of þ 0.1, þ 0.5 and
þ 1.0 kcalmol 1. These repulsive interactions were balanced by
favourable interactions between sidechains of CDR2a and the a2
helix, consisting of hydrogen bonds with strengths of  1.0 and
 0.7 kcalmol 1.
The interaction between Tyr50 of CDR2a and Gln155 of the
a2 helix is of interest given descriptions of conserved interactions
occurring between germline loops of TCRs and the a helices of
MHC proteins22,23. The A6 TCR shares the Va 12-2 domain with
two other TCRs that have been crystallized with peptide/HLA-A2
complexes24,25. Although there are no conserved contacts
between the TCRs and HLA-A2 in these structures, there is a
shared pattern of interactions involving Tyr50 of CDR2a and
Gln155 (ref. 24). The interaction between Tyr50a and Gln155 in
the A6-Tax/HLA-A2 was indeed favourable, although only
moderately so, with a DGint of  0.6 kcalmol 1. The adjacent
hydrogen bond between Asn52 of CDR2a and Glu166 of the
HLA-A2 a2 helix was more favourable at  1.1 kcalmol 1,
but this hydrogen bond is not conserved in the three Va 12-2
TCR-peptide/HLA-A2 interfaces24.
The interactions between the HV4a loop and HLA-A2,
involving electrostatic interactions between Lys68a and Thr163
and Glu166, were moderate, with interaction free energies of
 0.9 and  0.7 kcalmol 1, respectively. The sole interaction
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Figure 3 | Cross-eyed stereo views of the interactions between sidechains of the HLA-A2 a1 and a2 helices and those of the A6 TCR. (a) Recognition of
the HLA-A2 a1 helix by sidechains of CDR1a and CDR3a is dominated by interactions between Arg65 and the sidechains of Thr98a and Asp99a of the
CDR3a loop. The remainder of the interactions range from moderately unfavourable to moderately favourable. Interactions between sidechains are
highlighted by red lines, and the free energies of each interaction are indicated in units of kcalmol 1. (b) Recognition of the HLA-A2 a2 helix by sidechains
of CDR1a, CDR2a, CDR3b and HV4a proceeds via a range of moderately favourable to moderately unfavourable interactions.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2948
4 NATURE COMMUNICATIONS | 4:1948 | DOI: 10.1038/ncomms2948 | www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
between CDR3b and the a2 helix, between Pro103b and Gln155,
was also moderate, with a DGint of  0.7 kcalmol 1.
Contributions tabulated by interface component. The DGint
values from the double-mutant cycles in the A6-Tax/HLA-A2
interface are arranged according to CDR loop in Fig. 4. The
extremely favourable interactions between sidechains of CDR3a
and the HLA-A2 a1 helix are especially clear, as are the favour-
able interactions between sidechains of the two CDR1 loops and
the peptide. Also of interest are the opposing interactions between
the peptide and CDR3a (unfavourable), and the peptide and
CDR3b (favourable). Note that the summation in Fig. 4 assumes
additivity with caveats as discussed below. However, as noted
earlier the results explain a wealth of functional data, and the
distribution in Fig. 4 agrees well with computational calculations
on the distribution of energy in the A6-Tax/HLA-A2 interface26.
In addition to global effects, including changes in flexibility
that propagate away from the binding sites27 and the loss in
rotational/translational entropy that occurs upon binding
(estimated at 4–6 kcalmol 1)28,29, a notable component
missing from our analysis is interactions with backbone atoms,
which cannot be probed by double-mutant cycles. Within the
A6-Tax/HLA-A2 interface there are three backbone-mediated
hydrogen bonds, all to the peptide (Fig. 4c). Two are between the
carbonyl oxygen of pGly4 and Ser100 of CDR3a. The third is
between the carbonyl oxygen of pLeu2 and Gln30 of CDR1a. The
majority of hydrogen bonds within protein structures have been
found to be modestly favourable (a recent analysis of double-
mutant cycles found an average strength of  0.5 kcalmol 1
(ref. 30)). Our analysis thus likely underestimates the favourable
contributions of CDR1a and CDR3a to recognition of the Tax
peptide, but not to an extent that would alter our conclusions.
Shared interactions between Va 12-2 TCRs and HLA-A2 are weak.
As noted above, Tyr50 of CDR2a and Gln155 of HLA-A2 share a
pattern of interactions in three Va 12-2 TCR-peptide/HLA-A2
interfaces29,30. We therefore probed the interaction between
Tyr50a and Gln155 in the interface between the Va 12-2 TCR
DMF5 and its MART-126(27L)-35/HLA-A2 ligand. The strength of
this interaction was identical to that measured in the A6 interface,
with a weak DGint of  0.6 kcalmol 1 (Fig. 5). We also probed
the interaction between Asn52a and Glu166 in the DMF5
interface, as these sidechains also interact in both the A6 and
DMF5 interfaces, although the hydrogen bond is not present with
DMF5. Consistent with the structural differences, the strength of
the interaction was weaker in the DMF5 interface, with a DGint of
only  0.3 kcalmol 1 with DMF5 (compared with
 1.1 kcalmol 1 with A6).
Analysis of the B7 TCR supports conclusions drawn from A6.
The B7 TCR also recognizes the Tax peptide presented by HLA-
A2, allowing us to ask to what extent observations made with A6
are shared with B7. As with A6, the B7 TCR accommodates the
pTyr5 sidechain in a pocket formed by the CDR3a and CDR3b
loops. However, the two pockets have opposing electrostatics: the
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pocket is positively charged in A6, whereas in B7 it is negatively
charged owing to the presence of Asp30 of B7 the CDR1a loop.
The interaction between Asp30a of B7 and pTyr5 was found to
be very strong, with a DGint of  3.8 kcalmol 1 for a double-
mutant cycle using alanine at position 5 (Fig. 6a). However, this
cannot be attributable to the hydrogen bond to Asp30a, as a
cycle with phenylalanine yielded a weak DGint of only
 0.2 kcalmol 1. The interaction between Tyr104 of CDR3b
and pTyr5 was stronger, with a DGint of  0.8 kcalmol 1.
Although these cycles do not probe the entirety of B7 contacts to
pTyr5, they are nonetheless instructive: engagement of pTyr5 by
A6 is negligible, whereas it seems very favourable with B7. As the
difference cannot be attributed to hydrogen bonds, it may arise
from differences in packing and flexibility between the two TCRs,
resulting in an entropic penalty with A6 not present with B7. This
interpretation is supported by the specificities of the two TCRs:
A6 tolerates a wide range of modifications to the centre of the
peptide, yet B7 will only recognize targets with a tyrosine or a
phenylalanine at position 5 (ref. 14).
The B7 TCR utilizes the same Vb 13-2 gene segment as A6,
and the A6 and B7 CDR1b loops are positioned similarly over the
peptide carboxy terminal end31. A double-mutant cycle between
pTyr8 and Glu30b of B7 yielded a DGint of  1.6 kcalmol 1,
identical within error to that measured between pTyr8 and
Glu30b of A6 (Fig. 6b). Unlike the A6 TCR, the B7 CDR3b loop
does not interact with pTyr8, which may explain the greater
tolerance of B7 T cells to substitutions at position 8 (ref. 14).
Nonetheless, the presence of a strongly favourable hydrogen bond
from CDR1b to pTyr8 in both interfaces indicates that both TCRs
arrive at the same germline loop-driven solution for optimizing
electrostatic interactions with the peptide.
Lastly, we examined engagement of Arg65 on the HLA-A2 a1
helix by B7. In the B7 complex, Arg65 forms a salt bridge with
Glu94 of CDR3a, mimicking somewhat the salt bridge formed
between Arg65 and Asp99 of the A6 CDR3a loop. However,
compared with the highly favourable interaction formed in the
A6 complex, the strength of the salt bridge with B7 was more
modest, with a DGint of only  0.7 kcalmol 1. The differences
between A6 and B7 likely reflect the suboptimal arrangement
between the sidechains in the B7 interface (Fig. 6c). However,
with B7, Arg65 also forms two hydrogen bonds with the carbonyl
oxygen of Glu94a, which will likely provide additional favourable
free energy. The existence of a favourable interaction between
Arg65 and CDR3a of B7 is consistent with the observation that
the B7 TCR does not recognize Arg65 mutants in functional
assays5. Thus, both TCRs utilize CDR3a to productively engage
Arg65 of the HLA–A2 a1 helix.
Discussion
Owing to their usual location in the centre of the interface, the
central sidechains of a peptide are often assumed to be the focal
point in antigen-specific TCR recognition. This is not the case
with the A6 TCR: despite being accommodated in a central
pocket with multiple hydrogen bonds, engagement of the
sidechain of pTyr5 of the Tax peptide contributes little to
binding. This observation helps explain a key aspect of A6
crossreactivity: the receptor tolerates significant alterations at the
centre of the peptide14,15, with the CDR3b loop changing its
conformation significantly with different peptides13,15,16,18,19.
The high intrinsic flexibility of the A6 CDR3b loop13 likely
underlies the overall lack of stabilizing interactions between
CDR3b and the peptide centre, as the entropic cost of ordering
the loop will offset enthalpic gains from interatomic interactions.
Crossreactivity in the A6 TCR can thus be attributed to a
combination of flexibility and thermodynamic ambivalence (or
entropy/enthalpy compensation) at the centre of the interface.
This point is further established by the measurements with the B7
TCR: unlike A6, accommodation of pTyr5 by the B7 TCR is
favourable. Yet the B7 TCR is less accommodating to
substitutions at this position than A6 (ref. 14), and evidence
suggests that the B7 hypervariable loops are less flexible than
those of A6 (ref. 32).
Although flexibility and thermodynamic ambivalence at the
interface centre promotes A6 crossreactivity, this does not
exclude a role for the peptide centre and its interactions with
the TCR in defining some degree of specificity. A weak (or
neutral) interaction is better than an unfavourable interaction,
and the chemistry of the CDR3a/CDR3b loops and their
accessible conformations will limit what sidechains will be
tolerated. For example, A6 tolerates charged amino acids at
position 5 of the peptide poorly14. Flexibility and thermodynamic
ambivalence thus provides a mechanism for limited
crossreactivity (or equivalently, limited specificity), a hallmark
of T cell recognition. The TCR structural database indicates that
TCR CDR loop flexibility is concentrated in the hypervariable
loops33, indicating this strategy may be commonly utilized.
In contrast with the peptide centre, pTyr8 near the C-terminal
end dominates the peptide sidechain contributions to the binding
of A6, demonstrating the impact peripheral peptide residues
1α
D30α
Y5
Y104β
3β
–0.2
–3.8
–0.8
1α
E30β
Y8
–1.6
3α
E94α
R65
–0.7
a b c
Figure 6 | Select interactions in the B7-Tax/HLA-A2 interface for comparison with similar interactions in the A6-Tax/HLA-A2 interface.
(a) Engagement of pTyr5 of the Tax peptide is more substantive with B7 than with A6, but this is not attributable to hydrogen bonding. A double-mutant
cycle between pTyr5 and Asp30 of CDR1a yielded an interaction free energy of 0.2 kcalmol 1 with phenylalanine substituted for pTyr5. However, a cycle
with alanine yielded a much more substantial value of  3.8 kcalmol 1. The interaction between pTyr5 and Tyr104 of CDR3b yielded a moderate
interaction free energy of 0.8 kcalmol 1. (b) The hydrogen bond between Glu30 of CDR1b and pTyr8 of the Tax peptide is strong in the B7 interface,
with an interaction free energy of  1.6 kcalmol 1. An identical interaction with the same strength is formed in the interface with A6 (Fig. 2b). (c) The
hydrogen bond between Arg65 of the a1 helix and Glu94 of CDR3a in the interface with the B7 TCR is moderate, with an interaction free energy of
0.7 kcalmol 1. Arg65 also makes a bifurcated hydrogen bond with the carbonyl oxygen of Glu94, which as discussed in the text is also predicted to be
stabilizing.
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can have in TCR recognition. The interactions between the TCR
and pTyr8 are a strong element of peptide specificity, as a tyrosine
at position 8 is conserved in all known A6 agonists, and the
interactions with the pTyr8 sidechain are among the few
TCR–peptide interactions that are conserved in all ten crystal
structures of A6 bound to a pMHC10,12–16,18,19. Comparing
positions 5 and 8, the picture that emerges is that from a
free-energy perspective, pTyr8 acts as a ‘lynchpin’ for binding
of the A6 TCR, whereas pTyr5 is more of a neutral chemical
‘dollop’ around which the TCR moulds. It is notable that a
significant amount of favourable energy resulting from engaging
pTyr8 comes from the germline-encoded CDR1b loop,
demonstrating the importance germline loops can have in
determining antigen specificity. The observation that the B7
TCR utilizes CDR1b to make a similar stabilizing interaction with
pTyr8 reinforces this point.
Another striking observation is the dominance of the
interactions between the A6 hypervariable CDR3a loop and the
HLA-A2 a1 helix. This finding demonstrates conclusively that
TCR hypervariable loops can have a significant influence on
MHC restriction. Yet given the strength of these interactions, how
is it that the A6 TCR maintains sufficient peptide specificity to
have escaped the filtering process of negative selection?
Crucially, the interactions between CDR3a and Arg65 cannot
be considered in isolation, as their formation is dependent upon
the peptide. In the bound state, the conformation the flexible A6
CDR3a loop adopts is dependent on the need to avoid steric
clashes with other sidechains of HLA-A2 (ref. 13). However, this
conformation can only be reached because of the glycine at
peptide position 4: owing to steric crowding, any other amino
acid would prevent CDR3a from adopting its bound
conformation and making the crucial interactions with Arg65
(Fig. 7). Indeed, A6 is intolerant of any amino acid other than
glycine at position 4 (ref. 14). The peptide and MHC specificity of
the A6 TCR are therefore inextricably linked. Although the extent
to which similar results apply to other TCRs is unknown, this
finding underscores the limitations of perspectives that consider
MHC and peptide specificity as arising through independent
mechanisms.
The co-dependency of peptide and MHC specificity in the A6
TCR relates to the observation that the interactions between the
germline-encoded loops and the MHC a1/a2 helices range from
only moderately favourable to moderately unfavourable. This
includes germline–MHC interactions that are shared in interfaces
formed with multiple Va 12-2 TCRs29,30. The extent to which
evolution has influenced interactions between TCR germline
T98α carbonyl
D99α
D99α
T98α
T98α
carbonyl
CDR3α in bound A6CDR3α in free A6
Binding with CDR3α
conformational change
CDR3α in bound A6
T98α
T98α carbonyl
P4 ≠ Gly
D99α
R65
T98α
R65R65
pG4pG4
Steric clash
Steric clash
Binding prohibited
Figure 7 | The peptide and MHC specificity of the A6 TCR are inextricably linked. For TCR binding to proceed, the CDR3a loop must move from its
position in the unbound structure to its position in the bound13. The conformational change is driven in part by a steric clash that would occur between the
carbonyl oxygen of Thr98a and the sidechain of Arg65 (left panel). This conformational change permits formation of strongly stabilizing hydrogen
bonds from Thr98a and Asp99a to Arg65 (top right). However, if an amino acid other than glycine were present at peptide position 4, a steric clash would
occur between the Thr98a carboxyl and the position 4 b carbon (bottom right), preventing the loop from adopting its bound-state conformation and
interacting with Arg65. Thus, formation of the strong interactions between CDR3a and Arg65 is dependent on the presence of glycine at peptide position 4.
Glycine at position 4 is conserved in all known agonists for the A6 TCR.
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loops and MHC proteins is controversial34,35. As discussed above
though, weak interactions do not necessarily imply a lack of
specificity. One interpretation consistent with our data is that
rather than selecting for residues that will strongly stabilize the
interaction of a TCR with an MHC, evolution has selected for
sequences and conformations that can add some degree of
stabilization when germline loops are docked alongside the MHC
a helices, but can also ‘give’ when stronger interactions can be
made elsewhere35,36. An evolutionarily selected permissiveness
could explain not only the lack of strongly favourable germline–
MHC contacts in the interfaces explored here, but also
observations of non-canonical TCR-binding modes37, the
finding that changes to a peptide alone can alter receptor-
binding geometry24, the impact different CDR3 loops can have on
TCR–MHC contacts38 and the observation that TCRs that have
not undergone selection can engage non-MHC targets39. It can
also explain functional consequences of CDR2a mutations40, as
these will perturb the energetic balance that leads to
permissiveness. Such permissiveness may be a strategy for
ensuring that any given TCR is able to best optimize its
interactions with the composite peptide/MHC surface, and
provided it is still able to engage with a conducive geometry22,
initiate T cell signalling.
Methods
Proteins and peptides. TCRs and MHC proteins were refolded from bacterially
expressed inclusion bodies according to established procedures11. TCRs utilized an
engineered disulphide bond across the constant domains to ensure stability41.
Amino acids targeted for mutations were identified from the TCR–pMHC
structures using a 4Å cutoff. Mutations were generated from the wild-type
plasmids using PCR mutagenesis and confirmed by sequencing, or in some cases
were available from previous studies5,8,42. Peptides were either synthesized in-
house via solid-state synthesis using an ABI 433A instrument, or synthesized and
purified commercially (Genscript).
Double-mutant cycles. In a double-mutant cycle, the interaction free energy
between two amino-acid sidechains is determined via four measurements. The first
measures the DG for the interaction between the two wild-type proteins. The
second measures the effect of a single mutation on binding free energy (DDG1) and
the third measures the effect of a second mutation (DDG2), typically at a position
that interacts with the site of the first. The fourth measurement measures the
effect of both mutations simultaneously (DDG1;2). The measurements refer to a
cycle as shown in Fig. 1a. If there is no interaction (or coupling) between the two
mutated sites, then the consequences of both mutations simultaneously is equal to
the sum of the consequences of first and second mutations alone. Subject to the
caveats described below, the extent to which this relationship does not hold defines
the free energy of interaction between the two sidechains, that is:
DGint ¼DDG1;2 DDG1 DDG2 ð1Þ
which simplifies to:
DGint ¼DG1;2 DG1 DG2 þDGWT ð2Þ
where DG1;2 is the double-mutant binding free energy, DG1 the binding free energy
for the first single mutant, DG2 the binding free energy for the second single
mutant and DGWT the binding free energy for the wild-type proteins.
Surface plasmon resonance data collection and analysis. Double-mutant cycles
were performed with surface plasmon resonance utilizing a Biacore 3000 instru-
ment. Each cycle was performed with a strategy in which all four measurements
(wild type, first single mutant, second single mutant and the double mutant) were
performed in one experiment and fit globally. Wild-type and mutant TCR were
coupled to adjacent flow cells. Coupling levels were between 400 and 1,200 RU.
Two identical concentration series of wild-type and mutant pMHC were then
simultaneously injected over both flow cells in succession, using concentrations as
high as 400 mM, resulting in eight data sets for each cycle. All binding experiments
were performed at 25 C in 150mM NaCl, 3mM EDTA, 25mM HEPES, 0.005%
P-20, pH 7.4 using a steady-state equilibrium approach11. Data were processed
with BiaEvaluation 4.1.
For data analysis, after subtraction of the signal from a third blank flowcell, the
eight data sets for each cycle were simultaneously fit to a model in which the four
DG values and the surface activities of the two flow cells were fitted parameters.
Global fitting as was performed with custom scripts in OriginPro 7.5 or 9.0. This
strategy provides significant advantages over the traditional approach in which
individual measurements are made and each cycle constructed from independent
experiments, as it allows the determination of highly accurate DDG and DGint
values. Constraining the surface activities to values common to multiple data sets in
which one has higher affinity than the other greatly increases the affinity range of
surface plasmon resonance43, an advantage important for weak interactions
involving mutants. Global fitting of multiple data sets reduces the influence of data
set variation, enforces consistency and reduces parameter correlation44. Lastly,
when the same sensor surfaces and dilution series are utilized in a titration,
systematic errors such as instrumental noise and inaccuracies in protein
concentration cancel when differences in free energies (that is, DDG and DGint
values) are computed. This last point is crucial, as noise and concentration errors
contribute significantly to the error and uncertainty in low affinity measurements,
as they have a disproportionate impact on regions of a binding curve that
show large curvature. Note that because of this, in some cycles the measurements of
DDG and DGint may be more accurate than the individual DG measurements
comprising it, a caveat that has no impact on our results.
In almost all cases, the mutations in each double-mutant cycle were to alanine.
As indicated in Supplementary Tables S1 and S2, exceptions were leucine and
valine for Q30a of A6 (as the Q30aA mutant expressed poorly), asparagine for
D99a of A6 (to verify the strength of the interaction with R65 as described below),
both alanine and phenylalanine for pY5 and pY8 (to investigate contacts to the
tyrosine hydroxyl versus contacts to the aromatic ring) and glycine for A69 of
HLA-A2. In addition, cycles involving K66 of HLA-A2 were performed in the
background of the E63Q mutation to avoid complications arising from the complex
electrostatic environment at this position8. In B7, both alanine and phenylalanine
were substituted for pY5 to explore hydrogen bonding versus packing. Also
with B7, we utilized asparagine for Asp30a, as the D30aA mutant expressed poorly.
With the A6 TCR, five cycles yielded data in which the affinity of one or more
interactions was too weak to yield an accurate value of DGint (cycles in which
Asp99a was mutated to alanine and three of four cycles in which pPhe8 was
replaced with alanine or phenylalanine). These cycles were repeated with the high-
affinity TCR variant A6 c134 (CDR3b: 99MSAE102)20 or the fluorinated high-
affinity Tax peptide variant Y5FFF16. The Y5FFF substitution has been shown
previously to act independently of other substitutions in the interface, and select
cycles performed with and without the A6 c134 variant yielded the same
conclusions. Further, as shown in Supplementary Tables S1 and S2 and described
in the main text, the conclusions from the A6 D99a—HLA-A2 R65 and A6 E30b—
Tax pY8 cycles with the high-affinity variants were the same when performed in
the wild-type background but instead substituting asparagine for D99 and alanine
for pY8. The experiments with the DMF5 TCR utilized the high-affinity D26aY/
L98bW variant27.
In some instances (for example, Fig. 4b), we consider the effects of double-
mutant cycles in groups, a consideration that implicitly assumes additivity between
the measurements. The extent to which additivity is permissible depends upon
how well the chief assumptions in double-mutant cycles hold, that is, that the
mutations are structurally independent and that any perturbations resulting from
mutations are the same in the two single-mutant interfaces and the double-mutant
interface9. While these necessarily limiting assumptions are unlikely to be valid in
every instance, they have been supported when explicitly explored45. Support here
can be found in the cases where very similar or even identical DGint measurements
were obtained when cycles were repeated using different amino acids at a single
position (that is, Q30a-pL1, S31a-pY5, D99a-R65, E30b-pY8 and R95b-pY5
in the A6 interface). These measurements probed a range of environments,
including those with complex electrostatics (D99a-R65) and high intrinsic
flexibility (R95b-pY5).
Error propagation of DGint values was performed using standard statistical
error propagation methods11. When multiple measurements were available, the
values in the text and figures were the averages of the multiple measurements.
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